Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schorin, M. A.
Right arrow Articles by Sallan, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schorin, M. A.
Right arrow Articles by Sallan, S. E.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Journal of Clinical Oncology, Vol 12, 740-747, Copyright © 1994 by American Society of Clinical Oncology

ARTICLES

Treatment of childhood acute lymphoblastic leukemia: results of Dana- Farber Cancer Institute/Children's Hospital Acute Lymphoblastic Leukemia Consortium Protocol 85-01

MA Schorin, S Blattner, RD Gelber, NJ Tarbell, M Donnelly, V Dalton, HJ Cohen and SE Sallan
Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02115.

PURPOSE: The goals of this treatment program were as follows: to improve event-free survival (EFS) rates for high-risk (HR) patients by increasing the intensity of induction treatment; to improve EFS rates for infants by adding a special postinduction intensification; to treat the CNS using cranial irradiation doses that were lower than in our historic control group; and to confirm our previously obtained good results for children with T-cell disease. PATIENTS AND METHODS: Two hundred twenty children with acute lymphoblastic leukemia (ALL) from all risk groups, including infants and patients with T-cell disease, were treated between 1985 and 1987 with multiagent chemotherapy and cranial irradiation. RESULTS: The 7-year EFS rate (+/- SE) for all 220 patients was 78% +/- 3% at a median follow-up duration of 6.2 years, 89% +/- 4% for the 82 patients classified as standard risk (SR), and 72% +/- 4% for the remaining 138 patients classified as HR and very high risk (VHR). Eleven infants had an EFS rate of 55% +/- 15% that might be attributable to treatment with high doses of methotrexate and cytarabine (ara-c). Twenty children with T-cell disease had an EFS rate of 70% +/- 10%. CNS leukemia relapse (isolated or combined with bone marrow) occurred in four of 82 SR patients who received 18 Gy of cranial irradiation and four of 138 HR and VHR patients who received 24 Gy. CONCLUSION: This protocol, which featured early intensive treatment including asparaginase, doxorubicin, and cranial irradiation, provided good long-term disease control for children with ALL.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 JCOHome page
C. Oudot, M.-F. Auclerc, V. Levy, R. Porcher, C. Piguet, Y. Perel, V. Gandemer, M. Debre, C. Vermylen, B. Pautard, et al.
Prognostic Factors for Leukemic Induction Failure in Children With Acute Lymphoblastic Leukemia and Outcome After Salvage Therapy: The FRALLE 93 Study
J. Clin. Oncol., March 20, 2008; 26(9): 1496 - 1503.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
D. Douer, H. Yampolsky, L. J. Cohen, K. Watkins, A. M. Levine, A. P. Periclou, and V. I. Avramis
Pharmacodynamics and safety of intravenous pegaspargase during remission induction in adults aged 55 years or younger with newly diagnosed acute lymphoblastic leukemia
Blood, April 1, 2007; 109(7): 2744 - 2750.
[Abstract] [Full Text] [PDF]

Home page
 BiostatisticsHome page
G. M. Fitzmaurice, S. R. Lipsitz, J. G. Ibrahim, R. Gelber, and S. Lipshultz
Estimation in regression models for longitudinal binary data with outcome-dependent follow-up
Biostat., July 1, 2006; 7(3): 469 - 485.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. M. Goldberg, L. B. Silverman, D. E. Levy, V. K. Dalton, R. D. Gelber, L. Lehmann, H. J. Cohen, S. E. Sallan, and B. L. Asselin
Childhood T-Cell Acute Lymphoblastic Leukemia: The Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Experience
J. Clin. Oncol., October 1, 2003; 21(19): 3616 - 3622.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Krajinovic, D. Labuda, G. Mathonnet, M. Labuda, A. Moghrabi, J. Champagne, and D. Sinnett
Polymorphisms in Genes Encoding Drugs and Xenobiotic Metabolizing Enzymes, DNA Repair Enzymes, and Response to Treatment of Childhood Acute Lymphoblastic Leukemia
Clin. Cancer Res., March 1, 2002; 8(3): 802 - 810.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
B. J. Lange, B. C. Bostrom, J. M. Cherlow, M. G. Sensel, M. K. L. La, W. Rackoff, N. A. Heerema, R. S. Wimmer, M. E. Trigg, and H. N. Sather
Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group
Blood, February 1, 2002; 99(3): 825 - 833.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. M. LeClerc, A. L. Billett, R. D. Gelber, V. Dalton, N. Tarbell, J. M. Lipton, R. Barr, L. A. Clavell, B. Asselin, C. Hurwitz, et al.
Treatment of Childhood Acute Lymphoblastic Leukemia: Results of Dana-Farber ALL Consortium Protocol 87-01
J. Clin. Oncol., January 1, 2002; 20(1): 237 - 246.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
L. B. Silverman, R. D. Gelber, V. K. Dalton, B. L. Asselin, R. D. Barr, L. A. Clavell, C. A. Hurwitz, A. Moghrabi, Y. Samson, M. A. Schorin, et al.
Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01
Blood, March 1, 2001; 97(5): 1211 - 1218.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
P. R. Kearns, R. Pieters, M. M. A. Rottier, A. D. J. Pearson, and A. G. Hall
Raised blast glutathione levels are associated with an increased risk of relapse in childhood acute lymphocytic leukemia
Blood, January 15, 2001; 97(2): 393 - 398.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
K. A. Wheeler, S. M. Richards, C. C. Bailey, B. Gibson, I. M. Hann, F. G. H. Hill, and J. M. Chessells
Bone marrow transplantation versus chemotherapy in the treatment of very high-risk childhood acute lymphoblastic leukemia in first remission: results from Medical Research Council UKALL X and XI
Blood, October 1, 2000; 96(7): 2412 - 2418.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
L. A. Mattano Jr, H. N. Sather, M. E. Trigg, and J. B. Nachman
Osteonecrosis as a Complication of Treating Acute Lymphoblastic Leukemia in Children: A Report From the Children's Cancer Group
J. Clin. Oncol., September 18, 2000; 18(18): 3262 - 3272.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
T. C. Abshire, B. H. Pollock, A. L. Billett, P. Bradley, and G. R. Buchanan
Weekly polyethylene glycol conjugated L-asparaginase compared with biweekly dosing produces superior induction remission rates in childhood relapsed acute lymphoblastic leukemia: a pediatric oncology group study
Blood, September 1, 2000; 96(5): 1709 - 1715.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
F. M. Uckun, L. Stork, N. Seibel, M. Sarquis, C. Bedros, H. Sather, M. Sensel, G. H. Reaman, and P. S. Gaynon
Residual Bone Marrow Leukemic Progenitor Cell Burden after Induction Chemotherapy in Pediatric Patients with Acute Lymphoblastic Leukemia
Clin. Cancer Res., August 1, 2000; 6(8): 3123 - 3130.
[Abstract] [Full Text]

Home page
 The OncologistHome page
A. M. Friedmann and H. J. Weinstein
The Role of Prognostic Features in the Treatment of Childhood Acute Lymphoblastic Leukemia
Oncologist, August 1, 2000; 5(4): 321 - 328.
[Abstract] [Full Text]

Home page
 BloodHome page
N. L. R.-v. Woerden, R. Pieters, A. H. Loonen, I. Hubeek, E. van Drunen, H. B. Beverloo, R. M. Slater, J. Harbott, J. Seyfarth, E. R. van Wering, et al.
TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia
Blood, August 1, 2000; 96(3): 1094 - 1099.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Schrappe, A. Reiter, W.-D. Ludwig, J. Harbott, M. Zimmermann, W. Hiddemann, C. Niemeyer, G. Henze, A. Feldges, F. Zintl, et al.
Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90
Blood, June 1, 2000; 95(11): 3310 - 3322.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
G. Michel, J. Landman-Parker, M. F. Auclerc, C. Mathey, T. Leblanc, E. Legall, P. Bordigoni, J. P. Lamagnere, F. Demeocq, Y. Perel, et al.
Use of Recombinant Human Granulocyte Colony-Stimulating Factor to Increase Chemotherapy Dose-Intensity: A Randomized Trial in Very High-Risk Childhood Acute Lymphoblastic Leukemia
J. Clin. Oncol., April 7, 2000; 18(7): 1517 - 1524.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
D. H. Mahoney Jr, J. J. Shuster, R. Nitschke, S. Lauer, C. P. Steuber, and B. Camitta
Intensification With Intermediate-Dose Intravenous Methotrexate Is Effective Therapy for Children With Lower-Risk B-Precursor Acute Lymphoblastic Leukemia: A Pediatric Oncology Group Study
J. Clin. Oncol., March 13, 2000; 18(6): 1285 - 1294.
[Abstract] [Full Text] [PDF]

Home page
 International Journal of Behavioral DevelopmentHome page
P. Robaey, P. Dobkin, J.-M. Leclerc, F. Cyr, C. Sauerwein, and Y. Theoret
A comprehensive model of the development of mental handicap in children treated for acute lymphoblastic leukaemia: A synthesis of the literature
International Journal of Behavioral Development, March 1, 2000; 24(1): 44 - 58.
[Abstract] [PDF]

Home page
 ASH Education BookHome page
C. A. Felix, B. J. Lange, and J. M. Chessells
Pediatric Acute Lymphoblastic Leukemia: Challenges and Controversies in 2000
Hematology, January 1, 2000; 2000(1): 285 - 302.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. A. Cardoso, J. P. Veiga, P. Ghia, H. M. Afonso, W. N. Haining, S. E. Sallan, and L. M. Nadler
Adoptive T-Cell Therapy for B-Cell Acute Lymphoblastic Leukemia: Preclinical Studies
Blood, November 15, 1999; 94(10): 3531 - 3540.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
F. M. Uckun, P. S. Gaynon, D. O. Stram, M. G. Sensel, M. B. Sarquis, K. H. Lazarus, and M. Willoughby
Paucity of Leukemic Progenitor Cells in the Bone Marrow of Pediatric B-Lineage Acute Lymphoblastic Leukemia Patients with an Isolated Extramedullary First Relapse
Clin. Cancer Res., September 1, 1999; 5(9): 2415 - 2420.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
M. Zecca, A. Pession, C. Messina, F. Bonetti, C. Favre, A. Prete, S. Cesaro, F. Porta, I. Mazzarino, G. Giorgiani, et al.
Total Body Irradiation, Thiotepa, and Cyclophosphamide as a Conditioning Regimen for Children With Acute Lymphoblastic Leukemia in First or Second Remission Undergoing Bone Marrow Transplantation With HLA-Identical Siblings
J. Clin. Oncol., June 1, 1999; 17(6): 1838 - 1838.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
C.-H. Pui, J. M. Boyett, M. V. Relling, P. L. Harrison, G. K. Rivera, F. G. Behm, J. T. Sandlund, R. C. Ribeiro, J. E. Rubnitz, A. Gajjar, et al.
Sex Differences in Prognosis for Children With Acute Lymphoblastic Leukemia
J. Clin. Oncol., March 1, 1999; 17(3): 818 - 818.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
F. Boulad, P. Steinherz, B. Reyes, G. Heller, A. P. Gillio, T. N. Small, J. A. Brochstein, N. A. Kernan, and R. J. O'Reilly
Allogeneic Bone Marrow Transplantation Versus Chemotherapy for the Treatment of Childhood Acute Lymphoblastic Leukemia in Second Remission: A Single-Institution Study
J. Clin. Oncol., January 1, 1999; 17(1): 197 - 197.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. L. Loh, L. B. Silverman, M. L. Young, D. Neuberg, T. R. Golub, S. E. Sallan, and D. G. Gilliland
Incidence of TEL/AML1 Fusion in Children With Relapsed Acute Lymphoblastic Leukemia
Blood, December 15, 1998; 92(12): 4792 - 4797.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. A. Coulthard, C. Howell, J. Robson, and A. G. Hall
The Relationship Between Thiopurine Methyltransferase Activity and Genotype in Blasts From Patients With Acute Leukemia
Blood, October 15, 1998; 92(8): 2856 - 2862.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
C.-H. Pui and W. E. Evans
Acute Lymphoblastic Leukemia
N. Engl. J. Med., August 27, 1998; 339(9): 605 - 615.
[Full Text] [PDF]

Home page
 BloodHome page
M. C. Putti, R. Rondelli, M. G. Cocito, M. Arico, L. Sainati, V. Conter, C. Guglielmi, A. Cantu-Rajnoldi, R. Consolini, A. Pession, et al.
Expression of Myeloid Markers Lacks Prognostic Impact in Children Treated for Acute Lymphoblastic Leukemia: Italian Experience in AIEOP-ALL 88-91 Studies
Blood, August 1, 1998; 92(3): 795 - 801.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
C.-H. Pui, H. H. Mahmoud, G. K. Rivera, M. L. Hancock, J. T. Sandlund, F. G. Behm, D. R. Head, M. V. Relling, R. C. Ribeiro, J. E. Rubnitz, et al.
Early Intensification of Intrathecal Chemotherapy Virtually Eliminates Central Nervous System Relapse in Children With Acute Lymphoblastic Leukemia
Blood, July 15, 1998; 92(2): 411 - 415.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
F. M. Uckun, M. G. Sensel, L. Sun, P. G. Steinherz, M. E. Trigg, N. A. Heerema, H. N. Sather, G. H. Reaman, and P. S. Gaynon
Biology and Treatment of Childhood T-Lineage Acute Lymphoblastic Leukemia
Blood, February 1, 1998; 91(3): 735 - 746.
[Full Text] [PDF]

Home page
 BloodHome page
J. Harbott, S. Viehmann, A. Borkhardt, G. Henze, and F. Lampert
Incidence of TEL/AML1 Fusion Gene Analyzed Consecutively in Children With Acute Lymphoblastic Leukemia in Relapse
Blood, December 15, 1997; 90(12): 4933 - 4937.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
J. E. Rubnitz and C.-H. Pui
Childhood Acute Lymphoblastic Leukemia
Oncologist, December 1, 1997; 2(6): 374 - 380.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. P. Dibenedetto, L. Lo Nigro, S. Pine Mayer, G. Rovera, and G. Schiliro
Detectable Molecular Residual Disease at the Beginning of Maintenance Therapy Indicates Poor Outcome in Children With T-Cell Acute Lymphoblastic Leukemia
Blood, August 1, 1997; 90(3): 1226 - 1232.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
C.-H. Pui
Childhood Leukemias
N. Engl. J. Med., June 15, 1995; 332(24): 1618 - 1630.
[Full Text] [PDF]


About
JCO		 Editorial
Roster		 Advertising
Information		 Librarians &
Institutions		 Rights &
Permissions		 PDA Services

Copyright © 1994 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online